Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling.
Pati P, Karkampouna S, Bonollo F, Compérat E, Radić M, Spahn M, Martinelli A, Wartenberg M, Kruithof-de Julio M, Rapsomaniki M. Nat Mach Intell. 2024;6(9):1077-1093. doi: 10.1038/s42256-024-00889-5. Epub 2024 Sep 9.PMID: 39309216.
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
Küper AT, Kersting D, Telli T, Herrmann K, Rominger A, Afshar-Oromieh A, Lopes L, Karkampouna S, Shi K, Kim M, Hadaschik B, Darr C, Umutlu L, Fendler WP, Seifert R. Theranostics. 2024 Jun 11;14(9):3623-3633. doi: 10.7150/thno.96738. eCollection 2024.PMID: 38948055
Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
Brennen WN, Le Magnen C, Karkampouna S, Anselmino N, Bock N, Choo N, Clark AK, Coleman IM, Dolgos R, Ferguson AM, Goode DL, Krutihof-de Julio M, Navone NM, Nelson PS, O'Neill E, Porter LH, Ranasinghe W, Sunada T, Williams ED, Butler LM, Corey E, van Weerden WM, Taylor RA, Risbridger GP, Lawrence MG. Prostate. 2024 May;84(7):623-635. doi: 10.1002/pros.24682. Epub 2024 Mar 7.PMID: 38450798
Bladder cancer organoids as a functional system to model different disease stages and therapy response.
Minoli M, Cantore T, Hanhart D, Kiener M, Fedrizzi T, La Manna F, Karkampouna S, Chouvardas P, Genitsch V, Rodriguez-Calero A, Compérat E, Klima I, Gasperini P, Kiss B, Seiler R, Demichelis F, Thalmann GN, Kruithof-de Julio M.
Nat Commun. 2023 Apr 18;14(1):2214. doi: 10.1038/s41467-023-37696-2.PMID: 37072390
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Varadi M, Nagy N, Reis H, Hadaschik B, Niedworok C, Modos O, Szendroi A, Ablat J, Black PC, Keresztes D, Csizmarik A, Olah C, Gaisa NT, Kiss A, Timar J, Toth E, Csernak E, Gerstner A, Mittal V, Karkampouna S, Kruithof de Julio M, Gyorffy B, Bedics G, Rink M, Fisch M, Nyirady P, Szarvas T. Cancer Med. 2023 Apr;12(7):9041-9054. doi: 10.1002/cam4.5639. Epub 2023 Jan 20.PMID: 36670542
Role of prostate and bone stromal cells on prostate cancer progression.
Karkampouna S, Kruithof-de Julio M, Thalmann GN. Am J Clin Exp Urol. 2022 Jun 15;10(3):180-187. eCollection 2022.PMID: 35874291
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.
Kang J, La Manna F, Bonollo F, Sampson N, Alberts IL, Mingels C, Afshar-Oromieh A, Thalmann GN, Karkampouna S. Cancer Lett. 2022 Apr 1;530:156-169. doi: 10.1016/j.canlet.2022.01.015. Epub 2022 Jan 17.PMID: 35051532
NCBI Full Bibliography: https://www.ncbi.nlm.nih.gov/search/all/?term=karkampouna